Gosset

Gosset is an advanced drug intelligence platform designed for biotech and life sciences professionals who need fast, confident decision-making backed by comprehensive clinical evidence. The platform generates competitive landscapes, head-to-head comparisons, trial design benchmarks, and due diligence reports, all drawn from one of the most extensive clinical evidence databases in the industry.

Built by co-founders with deep expertise in AI and life sciences — including former Directors of AI at Clario and Stanford University researchers — Gosset combines rigorous scientific understanding with cutting-edge artificial intelligence to deliver actionable insights at scale.

Database Coverage

• Over 100,000 drugs indexed across the platform
• More than 120,000 companies tracked
• 23,000+ biological targets catalogued
• Over 1 million clinical trials included
• 400,000+ trial results available for analysis
• More than 100,000 deals recorded for due diligence and competitive research

Key Report Types and Use Cases

• Competitive landscape analysis to understand the positioning of drugs and programs within a therapeutic area
• Head-to-head comparisons between drugs or development programs
• Trial design benchmarks to inform and validate clinical development strategies
• Due diligence reports to support investment and partnership decisions

Who Gosset Is For

• Biotech and pharmaceutical teams seeking faster, evidence-based decision-making
• Business development and strategy professionals conducting due diligence
• Clinical development teams benchmarking trial designs against industry standards
• Investors and advisors evaluating drug programs and company pipelines

Gosset is backed by advisors and investors with backgrounds spanning Stanford University bioengineering, Oracle Life Sciences, Google, and AI-focused ventures. Teams can explore the platform through a 15-minute walkthrough call or request product information including features, use cases, and pricing details.